Search research articles
Contact Us
Filters
Showing results (91-100 of 165) with videos related to
Page
of 17
Sort By:
BMC Cancer
|
February 5, 2020
Prediction of patients with a tumor proportion score > 50% who do not respond to first-line monotherapy with pembrolizumab
Mitsunori Morita, Motohiro Tamiya, Daichi Fujimoto, et al.
Journal of Cardiovascular Computed Tomography
|
October 9, 2023
Coronary artery disease reporting and data system (CAD-RADS), vascular inflammation and plaque vulnerability
Daisuke Kinoshita, Keishi Suzuki, Haruhito Yuki, et al.
Journal of Cardiovascular Computed Tomography
|
September 25, 2024
Differences in total plaque burden between plaque rupture and plaque erosion: A combined computed tomography angiography and optical coherence tomography study
Takayuki Niida, Eisuke Usui, Keishi Suzuki, et al.
Internal Medicine (Tokyo, Japan)
|
November 3, 2015
Use of Coils and a Pulmonary Vasodilator to Reduce Pulmonary Hypertension in a Patient with Interstitial Pneumonia and Scleroderma
Gusti Rizky Teguh Ryanto, Kazuhiko Nakayama, Tomofumi Takaya, et al.
Atherosclerosis
|
May 13, 2025
Coronary spotty calcification, compared with macro calcification, is associated with a higher level of vascular inflammation and plaque vulnerability in patients with stable angina
Daichi Fujimoto, Daisuke Kinoshita, Keishi Suzuki, et al.
Scientific Reports
|
September 14, 2017
Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patients
Daichi Fujimoto, Keiichiro Uehara, Yuki Sato, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 21, 2022
Prospective multicenter cohort study of durvalumab for patients with unresectable stage III non-small cell lung cancer and grade 1 radiation pneumonitis
Takeya Sugimoto, Daichi Fujimoto, Yuki Sato, et al.
BMC Cancer
|
November 16, 2016
The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma
Yuki Sato, Daichi Fujimoto, Keiichiro Uehara, et al.
Anticancer Research
|
May 17, 2019
Association Between Formalin Fixation Time and Programmed Cell Death Ligand 1 Expression in Patients With Non-Small Cell Lung Cancer
Hayato Kawachi, Daichi Fujimoto, Daisuke Yamashita, et al.
Anticancer Research
|
December 4, 2018
Comparison of PD-L1 Assays in Non-small Cell Lung Cancer: 22C3 pharmDx and SP263
Daichi Fujimoto, Daisuke Yamashita, Junya Fukuoka, et al.
Page
of 17
Search research articles
Search
Showing results (91-100 of 165) with videos related to
Sort By:
Page
of 17
BMC Cancer
|
February 5, 2020
Prediction of patients with a tumor proportion score > 50% who do not respond to first-line monotherapy with pembrolizumab
Mitsunori Morita, Motohiro Tamiya, Daichi Fujimoto, et al.
Journal of Cardiovascular Computed Tomography
|
October 9, 2023
Coronary artery disease reporting and data system (CAD-RADS), vascular inflammation and plaque vulnerability
Daisuke Kinoshita, Keishi Suzuki, Haruhito Yuki, et al.
Journal of Cardiovascular Computed Tomography
|
September 25, 2024
Differences in total plaque burden between plaque rupture and plaque erosion: A combined computed tomography angiography and optical coherence tomography study
Takayuki Niida, Eisuke Usui, Keishi Suzuki, et al.
Internal Medicine (Tokyo, Japan)
|
November 3, 2015
Use of Coils and a Pulmonary Vasodilator to Reduce Pulmonary Hypertension in a Patient with Interstitial Pneumonia and Scleroderma
Gusti Rizky Teguh Ryanto, Kazuhiko Nakayama, Tomofumi Takaya, et al.
Atherosclerosis
|
May 13, 2025
Coronary spotty calcification, compared with macro calcification, is associated with a higher level of vascular inflammation and plaque vulnerability in patients with stable angina
Daichi Fujimoto, Daisuke Kinoshita, Keishi Suzuki, et al.
Scientific Reports
|
September 14, 2017
Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patients
Daichi Fujimoto, Keiichiro Uehara, Yuki Sato, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 21, 2022
Prospective multicenter cohort study of durvalumab for patients with unresectable stage III non-small cell lung cancer and grade 1 radiation pneumonitis
Takeya Sugimoto, Daichi Fujimoto, Yuki Sato, et al.
BMC Cancer
|
November 16, 2016
The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma
Yuki Sato, Daichi Fujimoto, Keiichiro Uehara, et al.
Anticancer Research
|
May 17, 2019
Association Between Formalin Fixation Time and Programmed Cell Death Ligand 1 Expression in Patients With Non-Small Cell Lung Cancer
Hayato Kawachi, Daichi Fujimoto, Daisuke Yamashita, et al.
Anticancer Research
|
December 4, 2018
Comparison of PD-L1 Assays in Non-small Cell Lung Cancer: 22C3 pharmDx and SP263
Daichi Fujimoto, Daisuke Yamashita, Junya Fukuoka, et al.
Page
of 17